Business Segments · Cost of products sold

MedSurg — Cost of products sold

Boston Scientific MedSurg — Cost of products sold increased by 9.5% to $529.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.3%, from $455.00M to $529.00M. Over 3 years (FY 2022 to FY 2025), MedSurg — Cost of products sold shows an upward trend with a 11.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025

How to read this metric

Rising costs relative to sales may indicate manufacturing inefficiencies or inflationary pressure on raw materials.

Detailed definition

The direct costs associated with manufacturing and delivering the products sold by the MedSurg segment. This includes ra...

Peer comparison

Standard cost of goods sold (COGS) metric for manufacturing-heavy business segments.

Metric ID: bsx_segment_medsurg_cost_of_products_sold

Historical Data

16 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$350.25M$350.25M$350.25M$350.25M$367.50M$367.50M$367.50M$367.50M$381.00M$401.00M$412.00M$455.00M$435.00M$470.00M$483.00M$529.00M
QoQ Change+0.0%+0.0%+0.0%+4.9%+0.0%+0.0%+0.0%+3.7%+5.2%+2.7%+10.4%-4.4%+8.0%+2.8%+9.5%
YoY Change+4.9%+4.9%+4.9%+4.9%+3.7%+9.1%+12.1%+23.8%+14.2%+17.2%+17.2%+16.3%
Range$350.25M$529.00M
CAGR+11.6%
Avg YoY Growth+11.1%
Median YoY Growth+10.6%
Current Streak3 quarters growth

Frequently Asked Questions

What is Boston Scientific's medsurg — cost of products sold?
Boston Scientific (BSX) reported medsurg — cost of products sold of $529.00M in Q4 2025.
How has Boston Scientific's medsurg — cost of products sold changed year-over-year?
Boston Scientific's medsurg — cost of products sold increased by 16.3% year-over-year, from $455.00M to $529.00M.
What is the long-term trend for Boston Scientific's medsurg — cost of products sold?
Over 3 years (2022 to 2025), Boston Scientific's medsurg — cost of products sold has grown at a 11.0% compound annual growth rate (CAGR), from $1.40B to $1.92B.
What does medsurg — cost of products sold mean?
The total direct cost to produce and deliver the goods sold by the MedSurg segment.